Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Goodkin

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
Applied Neuropsychology|December 14, 2004
HUMANS: An English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals--initial reportFrances L Wilkie, Karl Goodkin, Alfredo Ardila, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2003
Cognitive functioning in younger and older HIV-1-infected adultsFrances L Wilkie, Karl Goodkin, Imad Khamis, et al.
AJNR. American Journal of Neuroradiology|February 16, 2002
Effects of physiologic human brain motion on proton spectroscopy: quantitative analysis and correction with cardiac gatingPradip M Pattany, Imad H Khamis, Brian C Bowen, et al.
Applied Neuropsychology. Adult|October 8, 2016
Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adultsEnrique López, Alexander J Steiner, Kimberly Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2003
"Putting a face" on HIV infection/AIDS in older adults: a psychosocial contextKarl Goodkin, Timothy Heckman, Karolynn Siegel, et al.
Open Forum Infectious Diseases|February 2, 2023
Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIVJennifer A Manuzak, Janeway Granche, Katherine Tassiopoulos, et al.
Neuropsychiatry|July 31, 2012
A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disordersKarl Goodkin, Francisco Fernandez, Marshall Forstein, et al.
Frontiers in Cellular Neuroscience|May 19, 2023
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatmentKarl Goodkin, Teresa H Evering, Albert M Anderson, et al.
Journal of Neurovirology|August 1, 2006
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairmentKarl Goodkin, Benedetto Vitiello, William D Lyman, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
Applied Neuropsychology|December 14, 2004
HUMANS: An English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals--initial reportFrances L Wilkie, Karl Goodkin, Alfredo Ardila, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2003
Cognitive functioning in younger and older HIV-1-infected adultsFrances L Wilkie, Karl Goodkin, Imad Khamis, et al.
AJNR. American Journal of Neuroradiology|February 16, 2002
Effects of physiologic human brain motion on proton spectroscopy: quantitative analysis and correction with cardiac gatingPradip M Pattany, Imad H Khamis, Brian C Bowen, et al.
Applied Neuropsychology. Adult|October 8, 2016
Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adultsEnrique López, Alexander J Steiner, Kimberly Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2003
"Putting a face" on HIV infection/AIDS in older adults: a psychosocial contextKarl Goodkin, Timothy Heckman, Karolynn Siegel, et al.
Open Forum Infectious Diseases|February 2, 2023
Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIVJennifer A Manuzak, Janeway Granche, Katherine Tassiopoulos, et al.
Neuropsychiatry|July 31, 2012
A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disordersKarl Goodkin, Francisco Fernandez, Marshall Forstein, et al.
Frontiers in Cellular Neuroscience|May 19, 2023
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatmentKarl Goodkin, Teresa H Evering, Albert M Anderson, et al.
Journal of Neurovirology|August 1, 2006
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairmentKarl Goodkin, Benedetto Vitiello, William D Lyman, et al.
Pageof 6